ESR1 and breast carcinoma: Methionine at amino acid position 1,915 of BRCA2 (rs4987117) was less frequent (OR 0.39, 95% CI 0.19 – 0.82, p = 0.013) in estrogen receptor-positive patients of a study cohort of 117 sporadic breast cancer cases from Poland [16].